Vivo Capital, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2021$9,838,000
-10.2%
525,2620.0%0.44%
-6.8%
Q2 2021$10,952,000
-26.2%
525,2620.0%0.47%
-9.2%
Q1 2021$14,849,000
-13.4%
525,2620.0%0.52%
-31.9%
Q4 2020$17,155,000
-46.7%
525,262
-50.0%
0.77%
-58.8%
Q3 2020$32,172,000
+88.0%
1,050,0000.0%1.86%
+51.5%
Q2 2020$17,115,0001,050,0001.23%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders